Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2009 1
2010 1
2011 2
2012 2
2013 2
2014 2
2015 3
2016 6
2017 7
2018 2
2019 8
2020 5
2021 4
2022 6
2023 1
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

49 results

Results by year

Filters applied: . Clear all
Page 1
A phenotypic screening approach to target p60AmotL2-expressing invasive cancer cells.
Fonseca P, Cui W, Struyf N, Tong L, Chaurasiya A, Casagrande F, Zhao H, Fernando D, Chen X, Tobin NP, Seashore-Ludlow B, Lundqvist A, Hartman J, Göndör A, Östling P, Holmgren L. Fonseca P, et al. Among authors: tobin np. J Exp Clin Cancer Res. 2024 Apr 9;43(1):107. doi: 10.1186/s13046-024-03031-w. J Exp Clin Cancer Res. 2024. PMID: 38594748 Free PMC article.
Renal cell carcinoma escapes NK cell-mediated immune surveillance through the downregulation of DNAM-1.
Tong L, Kremer V, Neo SY, Liu Y, Chen Y, Wagner AK, Yang Y, Chen Z, Seitz C, Tobin NP, Ligtenberg MA, Alici E, Chen X, Haglund F, Seliger B, Harmenberg U, Colón E, Plogell AS, Liu LL, Lundqvist A. Tong L, et al. Cancer Commun (Lond). 2023 Jul;43(7):855-859. doi: 10.1002/cac2.12446. Epub 2023 Jun 14. Cancer Commun (Lond). 2023. PMID: 37314951 Free PMC article. No abstract available.
Twenty-Year Benefit From Adjuvant Goserelin and Tamoxifen in Premenopausal Patients With Breast Cancer in a Controlled Randomized Clinical Trial.
Johansson A, Dar H, van 't Veer LJ, Tobin NP, Perez-Tenorio G, Nordenskjöld A, Johansson U, Hartman J, Skoog L, Yau C, Benz CC, Esserman LJ, Stål O, Nordenskjöld B, Fornander T, Lindström LS. Johansson A, et al. Among authors: tobin np. J Clin Oncol. 2022 Dec 10;40(35):4071-4082. doi: 10.1200/JCO.21.02844. Epub 2022 Jul 21. J Clin Oncol. 2022. PMID: 35862873 Free PMC article. Clinical Trial.
Clinical and molecular characteristics of estrogen receptor-positive ultralow risk breast cancer tumors identified by the 70-gene signature.
Johansson A, Yu NY, Iftimi A, Tobin NP, van 't Veer L, Nordenskjöld B, Benz CC, Fornander T, Perez-Tenorio G, Stål O, Esserman LJ, Yau C, Lindström LS. Johansson A, et al. Among authors: tobin np. Int J Cancer. 2022 Jun 15;150(12):2072-2082. doi: 10.1002/ijc.33969. Epub 2022 Mar 7. Int J Cancer. 2022. PMID: 35179782 Free PMC article.
Interval breast cancer is associated with interferon immune response.
Ugalde-Morales E, Grassmann F, Humphreys K, Li J, Eriksson M, Tobin NP, Lindström LS, Vallon-Christersson J, Borg Å, Hall P, Czene K. Ugalde-Morales E, et al. Among authors: tobin np. Eur J Cancer. 2022 Feb;162:194-205. doi: 10.1016/j.ejca.2021.12.003. Epub 2022 Jan 10. Eur J Cancer. 2022. PMID: 35026490 Free article.
Novel loss-of-function variant in DENND5A impedes melanosomal cargo transport and predisposes to familial cutaneous melanoma.
Yang M, Johnsson P, Bräutigam L, Yang XR, Thrane K, Gao J, Tobin NP, Zhou Y, Yu R, Nagy N, Engström PG, Tuominen R, Eriksson H, Lundeberg J, Tucker MA, Goldstein AM, Egyhazi-Brage S, Zhao J, Cao Y, Höiom V. Yang M, et al. Among authors: tobin np. Genet Med. 2022 Jan;24(1):157-169. doi: 10.1016/j.gim.2021.09.003. Epub 2021 Nov 30. Genet Med. 2022. PMID: 34906508 Free PMC article.
49 results